Watson
Pfizer teams up with IBM Watson Health in immuno-oncology
December 2, 2016Medical Communications Pfizer, Watson, Watson Health, drug discovery, ibm
Pfizer and IBM Watson Health have announced a joint venture to accelerate research in immuno-oncology. Pfizer will use IBM’s Watson …
Celgene partners with IBM for new pharmacovigilance platform
November 2, 2016Research and Development, Sales and Marketing Celgene, Watson, ibm
IBM is set to join forces with Celgene to develop a new drug safety evaluation platform, it has emerged. Running …
Dendreon chief resigns from struggling firm
June 10, 2014Medical Communications, Sales and Marketing Cancer, Dendreon, John Johnson, Provenge, Vaccine, Watson, prostate
Chief executive of Dendreon John Johnson is to step down in the summer amid falling sales of the company’s key …
ABPI hires new head of Commercial
May 22, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Watson
The ABPI has appointed David Watson as its new head of Commercial, who will be reporting to the association’s Commercial …
AstraZeneca settles Crestor case
March 26, 2013Sales and Marketing AstraZeneca, Crestor, Watson
AstraZeneca has settled a long-running legal battle over one of its biggest brands, Crestor, whose patent expires in 2016. The …
Actavis to invest in Florida facility
March 25, 2013Manufacturing and Production Actavis, Watson
Actavis has announced a $40.5 million investment round at its plant in Davie, Florida, that looks set to create around …
Watson: the supercomputer revolution begins here
February 21, 2013Medical Communications Watson, ibm
Watson, a supercomputer developed by IBM is to make its debut helping oncologists diagnose and choose the best treatment for …
Watson buys women’s health specialists
January 23, 2013Research and Development, Sales and Marketing Actavis, Uteron, Watson, women
Watson has completed the acquisition of Uteron Pharma, a Belgium R&D-based firm specialising in women’s health products. The world’s third-largest …
Ark Therapeutics appoints new head of business development
June 12, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ark Therapeutics, Bachem, Eden Biodesign, Watson
Ark Therapeutics has announced that Kassim Kolia has been appointed as head of business development. In this role, Kolia will …
Watson buys Actavis to create generics giant
April 27, 2012Sales and Marketing Actavis, Watson, generics
Watson Pharmaceuticals is to buy rival Actavis Group in a move that will create the third largest generics manufacturer in …
Watson launches first generic Lipitor in US
November 30, 2011Sales and Marketing Lipitor, Pfizer, Watson, atorvastin
Watson Pharmaceuticals has launched its generic version of Pfizer’s blockbuster statin Lipitor as the drug goes off patent in the …
Watson submits Crestor copycat
October 28, 2010Sales and Marketing AstraZeneca, Crestor, Watson, generic, patent
Watson Pharmaceuticals is seeking to launch a generic version of AstraZeneca cholesterol blockbuster Crestor, exploiting weaknesses in its patent. The …
Emergency contraceptive proves controversial in US
August 16, 2010Sales and Marketing Ella, Plan B, Watson, emergency contraceptive
The FDA has approved HRA Pharma’s emergency contraceptive pill Ella but has been criticised by conservative ‘pro-life’ groups. French company …
